Skip to main content

Eurobio Scientific to Distribute NG Biotech Coronavirus Serology Test in France

NEW YORK – Eurobio Scientific and NG Biotech announced on Tuesday a deal to distribute a rapid serology test for SARS-CoV-2 to health professionals and nursing homes in France.

The deal is for NG Biotech's COVID-19 NG-Test IgG-IgM test, which detects and differentiates the presence of IgG and IgM antibodies to the coronavirus. Results can be achieved in 15 minutes, the companies said.

Financial and other terms of the deal were not disclosed.

"After the launch of our molecular biology offers and our automated serology offer, this marketing agreement with NG Biotech perfectly complements the diagnostic arsenal that we can make available to our customers to deal with the COVID-19 crisis," Eurobio Scientific President and CEO Jean-Michel Carle said in a statement. Formerly called Diaxonhit, the firm is based in France.

NG Biotech is also based in France and develops rapid diagnostics tests.